Platinum Investment Management LTD Avidity Biosciences, Inc. Transaction History

Platinum Investment Management LTD

  • $2.16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$20.4 - $28.66 $1.93 Million - $2.71 Million
-94,496 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
$18.16 - $25.21 $1.44 Million - $2 Million
79,496 Added 529.97%
94,496 $2.33 Million
Q2 2020

Aug 06, 2020
BUY
$26.62 - $31.5 $399,300 - $472,500
15,000 New
15,000 $424,000

Others Institutions Holding RNA

# of Institutions
255
Shares Held
107M
Call Options Held
224K
Put Options Held
161K
View Full List

About Avidity Biosciences, Inc.

RNA Quotes by TradingView
  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.66B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email